Vireo Growth Inc. (VREOF)
About Vireo Growth Inc.
VIREO GROWTH INC
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $268.8M
- Net income
- -$68.1M
- Total assets
- $817.2M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Vireo Growth Inc. (VREOF) Stock Price
- Reported a net loss of $68.1M in FY2025.
- Trading 54% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Vireo Growth Inc..
Write a review
Vireo Growth Inc.: frequently asked questions
Is Vireo Growth Inc. an American company?
Vireo Growth Inc. is a US-based company headquartered in Minneapolis, Minnesota, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Vireo Growth Inc. headquartered?
Vireo Growth Inc. is headquartered in Minneapolis, Minnesota, United States.
Is Vireo Growth Inc. publicly traded?
Yes — Vireo Growth Inc. is a publicly traded company. Its stock trades under the ticker symbol VREOF on the OTC.
What does Vireo Growth Inc. do?
Vireo Growth Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
